
Home
Chapter Home
Jobs
Conferences
Fellowships
Books
Advertisement
Bladder
Nonurothelial benign tumors
Inflammatory myofibroblastic tumor (IMT)
Reviewer: Monika Roychowdhury, M.D., University of Minnesota Medical Center (see Reviewers page)
Revised: 25 April 2011, last major update April 2011
Copyright: (c) 2003-2011, PathologyOutlines.com, Inc.
Definition
=========================================================================
● Rare myofibroblastic spindle cell neoplasm of bladder with unknown neoplastic potential, more common at other sites (lung most common followed by soft tissue, bone)
● Similar to postoperative spindle cell nodule, but without a history of surgery
● Characterized by spindle cell proliferation with characteristic fibroinflammatory and pseudosarcomatous appearance
Terminology
=========================================================================
● Inflammatory myofibroblastic tumor (IMT) is terminology for neoplastic lesions
● Inflammatory lesions are often called pseudotumors
● Also known as pseudosarcoma, atypical myfibroblastic tumor, atypical fibromyxoid tumor, plasma cell granuloma
Epidemiology
=========================================================================
● More common in children and young adults
● More common in females
Sites
=========================================================================
● Bladder is most common site in genitourinary tract
Etiology
=========================================================================
● Idiopathic, no known predisposing conditions
Clinical features
=========================================================================
● Pain, fever, weight loss, anemia, thrombocytosis, increased erythrocyte sedimentation rate and elevated gamma globulins are more common with IMTs arising at sites other than bladder
● IMTs in bladder present with painless hematuria
● Benign, but frequently misinterpreted as leiomyosarcoma or rhabdomyosarcoma
● May recur locally, but doesn’t metastasize (Am J Surg Pathol 2006;30:1502)
Case reports
=========================================================================
● 2 year old with sclerosing tumor that massively infiltrated bladder wall (Am J Surg Pathol 1992;16:1233)
● 27 year old woman with coexisting lupus (Int J Urol 2008;15:182)
● 30 year old man (Urol Ann 2010;2:78)
● 36 year old woman with abdominal pain and gross hematuria (Diagn Pathol 2008 Mar 13;3:11)
Treatment
=========================================================================
● Conservative surgical excision, including in children (Pediatr Surg Int 2007;23:815)
Gross description
=========================================================================
● Polypoid mass with pale, firm cut surface
● May be very large
● Often gelatinous
Gross images
=========================================================================

White, gelatinous mass with cystic change and hemorrhage
Micro description
=========================================================================
● Essential criteria: spindled myoepithelial cell proliferation and lymphocytic infiltrate
● Patterns include:
(1) loose stellate cells with myxoid background containing scattered inflammatory cells (nodular fasciitis-like)
(2) spindle cells with a compact fascicular pattern (fibrohistiocytoma-like)
(3) sparse cellular, collagenous areas (desmoid-like)
(4) mixed
● Cells are stellate myofibroblasts with abundant eosinophilic cytoplasm, elongated nuclei
● May be cellular and infiltrative with mucosal ulceration, necrosis, cytologic atypia
Micro images
=========================================================================

Spindle cells and inflammatory cells in myxoid stroma

Resembles post-operative spindle cell nodule

Highly cellular spindle cell tumor with moderate atypia

AFIP (3rd Series) Fig. 2-71: abundant thin walled vessels

Myofibroblastic cells and inflammatory cells in edematous stroma

Focal inflammatory cells

Spindle cells within fibromyxoid matrix and inflammatory cells
![]()
Various images
![]()
Inflammatory myofibroblastic tumor composed of spindle cells and inflammatory cells with no atypia and no necrosis

Comparison with leiomyosarcoma and embryonal rhabdomyosarcoma

ALK1 expression
Other images
Positive stains
=========================================================================
● Smooth muscle actin, desmin, ALK1 (75-89%, (Am J Surg Pathol 2001;25:1364), vimentin, calponin
● Variable keratin (Hum Pathol 1994;25:181, Am J Surg Pathol 2006;30:787)
Negative stains
=========================================================================
● EMA, myogenin, p53 (Mod Pathol 2001;14:1043), h-caldesmon (Hum Pathol 1999;30:392)
Electron microscopy description
=========================================================================
● Myofibroblasts: bipolar cells with eosinophilic, elongated, tapering cytoplasmic processes without striation, central oval nuclei with smooth contours, open chromatin, occasional nucleoli
● No evidence of smooth muscle or skeletal muscle differentiation
EM images
=========================================================================
![]()
Myofibroblastic features of rough endoplasmic reticulum, peripheral smooth muscle myofilaments (long arrows),
fibronectin fibrils (short arrows)
Molecular description
=========================================================================
● Usually ALK+ or ALK gene rearrangements by FISH (Mod Pathol 2007;20:592, Am J Surg Pathol 2004;28:1609)
Molecular images
=========================================================================
![]()
ALK translocation is indicated by separation of green and orange probes of ALK gene in inflammatory myofibroblastic tumor (a), but not leiomyosarcoma (b)
![]()
FISH analysis
Differential diagnosis
=========================================================================
● Leiomyosarcoma: smooth muscle morphology, strong desmin staining, keratin negative (Am J Surg Pathol 1989;13:480)
● Neurofibroma: neural morphology, strong S100+
● Rhabdomyosarcoma in children: necrosis or myxoid degeneration, moderate/severe nuclear atypia, more mitotic figures, no myofibroblastic differentiation; myoD1+, myogenin+ (Arch Pathol Lab Med 2001;125:1070, Am J Surg Pathol 1995;19:1224)
● Sarcomatoid (spindle cell) carcinoma
Additional references
=========================================================================
● Hum Pathol 1993;24:1203, Am J Surg Pathol 1993;17:264, Am J Surg Pathol 1985;9:366
● Am J Clin Path 1986;86:583, eMedicine
End of Bladder > Nonurothelial benign tumors > Inflammatory myofibroblastic tumor (IMT)
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other
contact information).